Insider · CIK 0001242215
PAPA JOSEPH C
Reports to the SEC for 10 companies · NEEDHAM, MA
Transactions
50
Companies
10
Filings
15
CIK
0001242215
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-30 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | +$11.5K |
| 2026-06-30 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | +$11.5K |
| 2026-06-23 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-10 | MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-29 | EBSEmergent BioSolutions Inc.A Award | — |
| 2026-03-31 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | +$11.5K |
| 2026-03-05 | EBSEmergent BioSolutions Inc.F Tax Payment | −$313K |
| 2026-03-03 | EBSEmergent BioSolutions Inc. · Employee Stock Option (Right to buy)A Award | — |
| 2025-07-11 | MISTMilestone Pharmaceuticals Inc.A Award | — |
| 2025-07-11 | MISTMilestone Pharmaceuticals Inc. · Series A Common Warrants (right to buy)A Award | — |
| 2025-07-11 | MISTMilestone Pharmaceuticals Inc. · Series B Common Warrants (right to buy)A Award | — |
| 2025-06-25 | CADLCandel Therapeutics, Inc.A Award | +$300K |
| 2025-06-17 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-10 | MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-13 | EBSEmergent BioSolutions Inc.P Purchase | +$350K |
| 2025-03-12 | EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award | — |
| 2025-03-12 | EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award | — |
| 2025-03-06 | EBSEmergent BioSolutions Inc.A Award | — |
| 2025-03-06 | EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award | — |
| 2024-09-03 | MISTMilestone Pharmaceuticals Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-26 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-03-13 | EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award | — |
| 2023-06-28 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-16 | Prometheus Biosciences, Inc.D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-16 | Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-02 | Prometheus Biosciences, Inc.J Other | — |
| 2023-06-02 | Prometheus Biosciences, Inc.J Other | — |
| 2023-05-19 | Prometheus Biosciences, Inc.A Award | — |
| 2022-12-09 | CADLCandel Therapeutics, Inc.P Purchase | +$67.9K |
| 2022-12-08 | CADLCandel Therapeutics, Inc.P Purchase | +$5,123.8 |
| 2022-08-08 | CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-19 | Prometheus Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-05-10 | BHCBausch Health Companies Inc.M Exercise/Conversion | — |
| 2022-05-10 | BHCBausch Health Companies Inc.M Exercise/Conversion | — |
| 2022-05-10 | BHCBausch Health Companies Inc.M Exercise/Conversion | — |
| 2022-05-10 | BHCBausch Health Companies Inc.F Tax Payment | −$317K |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsA Award | — |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion | −$1.1M |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsA Award | — |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion | −$1.73M |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsA Award | — |
| 2022-05-10 | BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion | −$620K |
| 2022-05-05 | BLCOBausch & Lomb CorpA Award | — |
| 2022-05-05 | BLCOBausch & Lomb Corp · Non-Qualified Stock Options (right to purchase)A Award | — |
| 2022-03-03 | BHCBausch Health Companies Inc.F Tax Payment | −$299K |
Recent filings
- 4PAPA JOSEPH C0001193125-26-412655SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000018SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000016SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000014SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000012SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000010SEC(opens sec.gov)
- 4PAPA JOSEPH C0001242215-26-000008SEC(opens sec.gov)
- 4PAPA JOSEPH C0001415889-25-019770SEC(opens sec.gov)
- 4PAPA JOSEPH C0000950170-25-090191SEC(opens sec.gov)
- 4PAPA JOSEPH C0000950170-25-087697SEC(opens sec.gov)
- 4PAPA JOSEPH C0001415889-25-016932SEC(opens sec.gov)
- 4PAPA JOSEPH C0001367644-25-000127SEC(opens sec.gov)
- 4PAPA JOSEPH C0001367644-25-000058SEC(opens sec.gov)
- 4PAPA JOSEPH C0001367644-25-000048SEC(opens sec.gov)
- 4PAPA JOSEPH C0001415889-24-022914SEC(opens sec.gov)
Companies
- Allergan Finance LLCPresident & COO
- Bausch Health Companies Inc.DirectorBHC
- Bausch & Lomb CorpDirector, See RemarksBLCO
- Candel Therapeutics, Inc.DirectorCADL
- CARDINAL HEALTH INCChmn & CEO, Pharm Techn & SvcsCAH
- Emergent BioSolutions Inc.Director, President and CEOEBS
- Milestone Pharmaceuticals Inc.DirectorMIST
- PERRIGO CODirector, President and CEO, Chairman
- PERRIGO Co plcDirector, CEO, ChairmanPRGO
- Prometheus Biosciences, Inc.Director
Address
C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450
NEEDHAM, MA, 02494